$113 Million is the total value of EMORY UNIVERSITY's 52 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 51.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $29,800,000 | +1.9% | 117 | 0.0% | 26.33% | -4.6% | |
| LOXO | New | LOXO ONCOLOGY INC | $2,738,000 | – | 34,143 | +100.0% | 2.42% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $2,164,000 | – | 46,766 | +100.0% | 1.91% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,038,000 | – | 202,357 | +100.0% | 1.80% | – |
| SMLP | SUMMIT MIDSTREAM PARTNERS LP | $1,983,000 | -5.6% | 87,560 | 0.0% | 1.75% | -11.6% | |
| AVXS | Sell | AVEXIS INC | $1,869,000 | -34.1% | 22,750 | -39.0% | 1.65% | -38.3% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $1,859,000 | -11.9% | 41,309 | -28.4% | 1.64% | -17.6% |
| NXTM | New | NXSTAGE MEDICAL INC | $1,804,000 | – | 71,954 | +100.0% | 1.59% | – |
| RTRX | New | RETROPHIN INC | $1,767,000 | – | 91,108 | +100.0% | 1.56% | – |
| BIVV | New | BIOVERATIV INC | $1,734,000 | – | 28,817 | +100.0% | 1.53% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $1,721,000 | – | 21,582 | +100.0% | 1.52% | – |
| ZGNX | Sell | ZOGENIX INC | $1,716,000 | -29.6% | 118,319 | -47.4% | 1.52% | -34.1% |
| VSAR | New | VERSARTIS INC | $1,709,000 | – | 97,944 | +100.0% | 1.51% | – |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $1,709,000 | -16.6% | 372,327 | -23.5% | 1.51% | -21.9% |
| GHDX | Sell | GENOMIC HEALTH INC | $1,708,000 | -29.4% | 52,459 | -31.7% | 1.51% | -33.9% |
| ADS | Sell | ALLIANCE DATA SYSTEMS CORP | $1,681,000 | -4.8% | 6,549 | -7.7% | 1.48% | -10.9% |
| LSXMK | Sell | LIBERTY MEDIA CORP DELAWARE | $1,675,000 | -5.4% | 40,161 | -12.1% | 1.48% | -11.5% |
| MS | Buy | MORGAN STANLEY | $1,673,000 | +9.1% | 37,548 | +4.9% | 1.48% | +2.1% |
| CBRE | Sell | CBRE GROUP INCcl a | $1,663,000 | +3.2% | 45,689 | -1.4% | 1.47% | -3.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $1,656,000 | -18.5% | 13,607 | -18.8% | 1.46% | -23.7% |
| WBC | Sell | WABCO HLDGS INC | $1,651,000 | +0.6% | 12,947 | -7.3% | 1.46% | -5.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $1,650,000 | -29.4% | 59,455 | -28.7% | 1.46% | -33.9% |
| AWI | Sell | ARMSTRONG WORLD INDS INC NEW | $1,648,000 | -11.2% | 35,831 | -11.0% | 1.46% | -16.8% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $1,634,000 | +6.1% | 25,600 | +9.6% | 1.44% | -0.8% |
| LEXEA | Sell | LIBERTY EXPEDIA HOLDINGS | $1,629,000 | -1.9% | 30,162 | -17.4% | 1.44% | -8.2% |
| WLTW | Sell | WILLIS TOWERS WATSON PUB LTD | $1,606,000 | -5.6% | 11,041 | -15.1% | 1.42% | -11.6% |
| FOX | Buy | TWENTY FIRST CENTY FOX INCcl b | $1,604,000 | -6.9% | 57,553 | +6.2% | 1.42% | -12.9% |
| MSFT | Sell | MICROSOFT CORP | $1,602,000 | -5.5% | 23,239 | -9.7% | 1.42% | -11.6% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $1,599,000 | -49.3% | 287,550 | -23.4% | 1.41% | -52.5% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $1,588,000 | -17.7% | 56,923 | +1.4% | 1.40% | -23.0% |
| VSAT | Sell | VIASAT INC | $1,586,000 | +2.5% | 23,955 | -1.2% | 1.40% | -4.1% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $1,585,000 | -28.4% | 44,391 | -29.4% | 1.40% | -33.0% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,584,000 | – | 46,979 | +100.0% | 1.40% | – |
| AXTA | New | AXALTA COATING SYS LTD | $1,581,000 | – | 49,331 | +100.0% | 1.40% | – |
| LVNTA | Sell | LIBERTY INTERACTIVE CORP | $1,577,000 | -4.4% | 30,156 | -18.7% | 1.39% | -10.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,574,000 | -24.6% | 17,330 | -27.2% | 1.39% | -29.5% |
| COMM | Sell | COMMSCOPE HLDG CO INC | $1,571,000 | -10.0% | 41,320 | -1.3% | 1.39% | -15.8% |
| KMI | Buy | KINDER MORGAN INC DEL | $1,522,000 | -3.0% | 79,457 | +10.1% | 1.34% | -9.2% |
| ACGL | Sell | ARCH CAP GROUP LTDord | $1,520,000 | -8.3% | 16,294 | -6.9% | 1.34% | -14.2% |
| MYOV | New | MYOVANT SCIENCES LTD | $1,512,000 | – | 129,228 | +100.0% | 1.34% | – |
| XNCR | New | XENCOR INC | $1,491,000 | – | 70,640 | +100.0% | 1.32% | – |
| AQXP | Sell | AQUINOX PHARMACEUTICALS INC | $1,489,000 | -20.4% | 105,815 | -5.6% | 1.32% | -25.5% |
| BHI | Buy | BAKER HUGHES INC | $1,465,000 | -7.5% | 26,867 | +1.5% | 1.29% | -13.4% |
| INCY | Sell | INCYTE CORP | $1,457,000 | -38.1% | 11,570 | -34.2% | 1.29% | -42.0% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $1,442,000 | – | 52,709 | +100.0% | 1.27% | – |
| STX | Buy | SEAGATE TECHNOLOGY PLC | $1,417,000 | -9.3% | 36,573 | +7.6% | 1.25% | -15.1% |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $1,410,000 | – | 47,353 | +100.0% | 1.25% | – |
| AKAOQ | New | ACHAOGEN INC | $1,402,000 | – | 64,513 | +100.0% | 1.24% | – |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $1,377,000 | -31.9% | 74,020 | +0.6% | 1.22% | -36.3% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,349,000 | – | 29,316 | +100.0% | 1.19% | – |
| SGEN | Sell | SEATTLE GENETICS INC | $1,226,000 | -43.7% | 23,704 | -31.6% | 1.08% | -47.3% |
| RARX | Sell | RA PHARMACEUTICALS INC | $1,183,000 | -46.4% | 63,144 | -39.1% | 1.04% | -49.8% |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -203,519 | -100.0% | -0.95% | – |
| TRN | Exit | TRINITY INDS INC | $0 | – | -57,885 | -100.0% | -1.45% | – |
| LPLA | Exit | LPL FINL HLDGS INC | $0 | – | -39,989 | -100.0% | -1.50% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -164,607 | -100.0% | -1.92% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -189,477 | -100.0% | -2.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
| 13F-HR | 2019-02-12 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.